CLINICAL_TRIALS
trial_result
· 2017-03-17
Clinical Trial Update: Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy [Phase 3]
Summary
A Phase 3 trial evaluating Brivaracetam as add-on therapy for adolescents and adults with epilepsy has completed, with results posted in March 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma SA | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2017-03-17